Search Results - "Feliciano, L. M."

Heteroresistance to Fluconazol in Clinical and Environmental Brazilian Strains of Cryptococcus neoformans/C. gattii Species Complex by Feliciano, L. M., Ramos, S. D. P., Szeszs, M. W., Martins, M. A., Bonfietti, L. X., Oliveira, R. A., Santos, D. C. S., Fadul, L. H., Silva, D. F., Paula, C. R., Trilles, L., Silva, L. E. A., Ferreira-Paim, K., Mora, D. J., Andrade, A. A., Silva, P. R., Silva-Vergara, M. L., Roberto, T. N., Melhem, M. S. C.

“…Purpose of Study To review the literature on heteroresistance to fluconazole (FLC) and investigate the level of heteroresistance to FLC (LHF), we analyzed 100…”
Get full text

Distribution and hydrolytic enzyme characteristics of Candida albicans strains isolated from diabetic patients and their non-diabetic consorts by Boriollo, M. F. G., Bassi, R. C., Dos Santos Nascimento, C. M. G., Feliciano, L. M., Francisco, S. B., Barros, L. M., Spolidório, L. C., Palomari Spolidório, D. M.

“…Introduction:  The aim of this study was to investigate the oral colonization profile of Candida albicans strains isolated from diabetic patients and their…”
Get full text

First-line Osimertinib for Lung Cancer With Uncommon EGFR Exon 19 Mutations and EGFR Compound Mutations by Cheunkarndee, Tia, Guo, Matthew Z., Houseknecht, Stefanie, Feliciano, Josephine L., Hann, Christine L., Lam, Vincent K., Levy, Benjamin P., Murray, Joseph C., Brahmer, Julie R., Forde, Patrick M., Marrone, Kristen A., Scott, Susan C.

“…Up to 20% of EGFR-mutated NSCLC cases harbor uncommon EGFR mutations, including atypical exon 19 and compound mutations. Relatively little is known about the…”
Get full text

Pretreatment Lung Function and Checkpoint Inhibitor Pneumonitis in NSCLC by Reuss, Joshua E., Brigham, Emily, Psoter, Kevin J., Voong, Khinh Ranh, Shankar, Bairavi, Ettinger, David S., Marrone, Kristen A., Hann, Christine L., Levy, Benjamin, Feliciano, Josephine L., Brahmer, Julie R., Feller-Kopman, David, Lerner, Andrew D., Lee, Hans, Yarmus, Lonny, Hales, Russell K., D’Alessio, Franco, Danoff, Sonye K., Forde, Patrick M., Suresh, Karthik, Naidoo, Jarushka

“…Checkpoint inhibitor pneumonitis (CIP) is a serious toxicity of anti–programmed death-(ligand) 1 immunotherapy. Whether pretreatment differences in pulmonary…”
Get full text

Plasma treatment of bulk niobium surface for superconducting rf cavities: Optimization of the experimental conditions on flat samples by Rašković, M., Upadhyay, J., Vušković, L., Popović, S., Valente-Feliciano, A-M., Phillips, L.

“…Accelerator performance, in particular the average accelerating field and the cavity quality factor, depends on the physical and chemical characteristics of…”
Get full text